Until recently, patients with severe aortic stenosis who were deemed too high risk for open-heart surgery did not have many other treatment options, but that’s all changing with TAVR. As a less invasive treatment approach, TAVR involves replacing the damaged valve with a newly designed balloon-expandable valve.
The valve is placed via a catheter that is inserted through a small incision in the leg. For patients with damaged valves who were previously ineligible for valve replacement, this means new hope.
Penn Heart and Vascular was the first program in the region and one of only 23 in the nation to perform TAVR. With more than 300 procedures performed to date, Penn’s highly specialized heart team has more experience performing TAVR than anywhere else in the region.
Learn more about Penn's Heart Valve Disease Program